In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories-Reference-Cited by-同舟云学术

In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories

Published:2018-10 Issue:10 Volume:62 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Pfaller Michael A.¹²,Rhomberg Paul R.¹,Wiederhold Nathan P.³^ORCID,Gibas Connie³,Sanders Carmita³,Fan Hongxin³,Mele James³,Kovanda Laura L.⁴^ORCID,Castanheira Mariana¹

Affiliation:

1. JMI Laboratories, North Liberty, Iowa, USA

2. University of Iowa College of Medicine, Iowa City, Iowa, USA

3. Fungus Testing Laboratory, University of Texas Health Science Center, San Antonio, Texas, USA

4. Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA

Abstract

Monitoring antifungal susceptibility patterns for new and established antifungal agents seems prudent given the increasing prevalence of uncommon species associated with higher antifungal resistance. We evaluated the activity of isavuconazole against 4,856 invasive yeasts and molds collected worldwide.

Funder

Astellas Pharma US

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01230-18

Reference76 articles.

1. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision

2. The Global Burden of Fungal Diseases

3. Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment